From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for
Pasello, Giulia
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for [electronic resource] - The oncologist 06 2019 - e318-e326 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
1549-490X
10.1634/theoncologist.2018-0712 doi
Adult
Afatinib--economics
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung--diagnosis
Cost-Benefit Analysis
Critical Pathways--standards
DNA Mutational Analysis--standards
Disease Progression
Disease-Free Survival
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride--economics
Female
Follow-Up Studies
Gefitinib--economics
Guideline Adherence--standards
Humans
Lung Neoplasms--diagnosis
Male
Middle Aged
Mutation
Practice Guidelines as Topic
Progression-Free Survival
Prospective Studies
Protein Kinase Inhibitors--economics
Time Factors
Treatment Failure
Assessment of Medication Adherence
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for [electronic resource] - The oncologist 06 2019 - e318-e326 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
1549-490X
10.1634/theoncologist.2018-0712 doi
Adult
Afatinib--economics
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung--diagnosis
Cost-Benefit Analysis
Critical Pathways--standards
DNA Mutational Analysis--standards
Disease Progression
Disease-Free Survival
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride--economics
Female
Follow-Up Studies
Gefitinib--economics
Guideline Adherence--standards
Humans
Lung Neoplasms--diagnosis
Male
Middle Aged
Mutation
Practice Guidelines as Topic
Progression-Free Survival
Prospective Studies
Protein Kinase Inhibitors--economics
Time Factors
Treatment Failure
Assessment of Medication Adherence